ArticleFrontiers in sports and active living2026
Effects of intermittent hypoxia and hypoxia-hyperoxia exposure on recovery from delayed onset muscle soreness in physically active men: protocol for a randomized controlled trial.
Article in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The objective of this study is to evaluate whether intermittent hypoxia can enhance physical recovery following the induction of delayed onset muscle soreness (DOMS). Methods and analysis: A randomized controlled trial will be conducted with male participants aged 18-35 years who engage in at least two organized training sessions per week. After a DOMS induction protocol targeting the hamstrings, participants will be randomized to receive either intermittent hypoxia, hypoxia-hyperoxia, or placebo for five consecutive days. During this period, several outcome variables will be assessed, including: cognitive function-attention and executive functions (D2 Test and Trail Making Test A and B); stress (DASS-21 questionnaire); physical performance-VO Ethics and disseminations: The study was reviewed and approved by the Medical Ethics Committee of Hospital Clínico San Carlos, Madrid, Spain (internal code 25/446-E) prior to data collection. If effective, intermittent hypoxia and hypoxia-hyperoxia could be implemented as non-pharmacological recovery strategies for athletes and physically active populations, offering a novel alternative to current methods with inconsistent results. The findings may guide future research on hypoxic conditioning, inform clinical practices for rehabilitation and performance recovery, and potentially shape policy regarding safe, evidence-based applications of hypoxia in sports medicine. Clinical Trial Registration: https://www.anzctr.org.au/, registration code ACTRN12625001404415.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.